Literature DB >> 26231149

Anterior cruciate ligament deficiency reduces walking economy in "copers" and "non-copers".

Efthymios Iliopoulos1, Nikiforos Galanis2, Michael Iosifidis3, Andreas Zafeiridis4, Pericles Papadopoulos5, Michael Potoupnis1, Nikolaos Geladas6, Ioannis S Vrabas4, John Kirkos1.   

Abstract

PURPOSE: Patients with ACL injury requiring surgical treatment (non-copers) demonstrate altered neuromuscular control and gait pattern compared with those returning to their pre-injury activities without surgery (copers). Pathological gait pattern may increase the energy cost of walking. We compared the energy cost of flat, uphill, and downhill walking between ACL-deficient and healthy individuals and between "copers" and "non-copers".
METHODS: Nineteen young males with unilateral ACL injury were allocated into "copers" and "non-copers" according to their ability to return to pre-injury activity without ACL reconstruction. Lysholm and IKDC scales were recorded, and a control group (n = 10) matched for physical characteristics and activity levels was included. All participants performed 8-min walking tasks at 0, +10, and -10 % gradients. Energy cost was assessed by measurement of oxygen consumption (VO2). HR and ventilation (VE), respiratory exchange ratio (RER), and VE/VO2 were also measured.
RESULTS: VO2 and HR were higher in ACL-deficient patients than in controls during walking at 0, +10, and -10 % gradients (p < 0.01-0.05). There were no differences between "copers" and "non-copers" in VO2 and HR for any gradient. No differences were observed in VE, RER, and VE/VO2 among the three groups.
CONCLUSIONS: The walking economy of level, uphill, and downhill walking is reduced in ACL-deficient patients. Despite the improved functional and clinical outcome of "copers", their walking economy appears similar to that of "non-copers" but impaired compared with healthy individuals. The higher energy demand and effort during locomotion in "copers" and "non-copers" has clinical implications for designing safer rehabilitation programmes. The increased energy cost in "copers" may be another parameter to consider when deciding on the most appropriate therapeutic intervention (operative and non-operative), particularly for athletes. LEVEL OF EVIDENCE: II.

Entities:  

Keywords:  ACL; ACL reconstruction; ACL-deficient; Energy cost; Energy expenditure; Oxygen consumption

Mesh:

Year:  2015        PMID: 26231149     DOI: 10.1007/s00167-015-3709-2

Source DB:  PubMed          Journal:  Knee Surg Sports Traumatol Arthrosc        ISSN: 0942-2056            Impact factor:   4.342


  43 in total

1.  Validation of the COSMED K4 b2 portable metabolic system.

Authors:  J E McLaughlin; G A King; E T Howley; D R Bassett; B E Ainsworth
Journal:  Int J Sports Med       Date:  2001-05       Impact factor: 3.118

2.  Knee instability after acute ACL rupture affects movement patterns during the mid-stance phase of gait.

Authors:  Wendy J Hurd; Lynn Snyder-Mackler
Journal:  J Orthop Res       Date:  2007-10       Impact factor: 3.494

Review 3.  A systematic literature review to investigate if we identify those patients who can cope with anterior cruciate ligament deficiency.

Authors:  Lee Herrington; Elizabeth Fowler
Journal:  Knee       Date:  2006-06-27       Impact factor: 2.199

Review 4.  The energy expenditure of normal and pathologic gait.

Authors:  R L Waters; S Mulroy
Journal:  Gait Posture       Date:  1999-07       Impact factor: 2.840

5.  Rating systems in the evaluation of knee ligament injuries.

Authors:  Y Tegner; J Lysholm
Journal:  Clin Orthop Relat Res       Date:  1985-09       Impact factor: 4.176

6.  Anterior cruciate ligament-deficient potential copers and noncopers reveal different isokinetic quadriceps strength profiles in the early stage after injury.

Authors:  Ingrid Eitzen; Thomas J Eitzen; Inger Holm; Lynn Snyder-Mackler; May Arna Risberg
Journal:  Am J Sports Med       Date:  2010-01-28       Impact factor: 6.202

7.  Atypical hamstrings electromyographic activity as a compensatory mechanism in anterior cruciate ligament deficiency.

Authors:  A L Boerboom; A L Hof; J P Halbertsma; J J van Raaij; W Schenk; R L Diercks; J R van Horn
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2001-07       Impact factor: 4.342

Review 8.  Identifying individuals with an anterior cruciate ligament-deficient knee as copers and noncopers: a narrative literature review.

Authors:  Yonatan Kaplan
Journal:  J Orthop Sports Phys Ther       Date:  2011-09-30       Impact factor: 4.751

9.  Laxity, instability, and functional outcome after ACL injury: copers versus noncopers.

Authors:  M E Eastlack; M J Axe; L Snyder-Mackler
Journal:  Med Sci Sports Exerc       Date:  1999-02       Impact factor: 5.411

10.  Test-retest reliability and minimum detectable change using the K4b2: oxygen consumption, gait efficiency, and heart rate for healthy adults during submaximal walking.

Authors:  Benjamin J Darter; Kelly M Rodriguez; Jason M Wilken
Journal:  Res Q Exerc Sport       Date:  2013-06       Impact factor: 2.500

View more
  3 in total

1.  Anatomic single-bundle anterior cruciate ligament reconstruction improves walking economy: hamstrings tendon versus patellar tendon grafts.

Authors:  Efthymios Iliopoulos; Nikiforos Galanis; Andreas Zafeiridis; Michael Iosifidis; Pericles Papadopoulos; Michael Potoupnis; Nikolaos Geladas; Ioannis S Vrabas; John Kirkos
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2016-07-01       Impact factor: 4.342

2.  Kinematics and arthrokinematics in the chronic ACL-deficient knee are altered even in the absence of instability symptoms.

Authors:  Chen Yang; Yasutaka Tashiro; Andrew Lynch; Freddie Fu; William Anderst
Journal:  Knee Surg Sports Traumatol Arthrosc       Date:  2017-11-09       Impact factor: 4.342

3.  Modeling and classification of gait patterns between anterior cruciate ligament deficient and intact knees based on phase space reconstruction, Euclidean distance and neural networks.

Authors:  Wenbao Wu; Wei Zeng; Limin Ma; Chengzhi Yuan; Yu Zhang
Journal:  Biomed Eng Online       Date:  2018-11-01       Impact factor: 2.819

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.